Carroll Financial Associates’s IGC Pharma IGC Stock Holding History

Carroll Financial Associates’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-320,000	Closed	-$572K	–	1757
2021 Q1	$572K	Sell	320,000 -125,000	-28%	-$227K	0.04%	234
2020 Q4	$694K	Sell	445,000 -70,000	-14%	-$103K	0.05%	195
2020 Q3	$535K	Hold	515,000	–	–	0.04%	210
2020 Q2	$308K	Buy	515,000 +300,000	+140%	+$163K	0.03%	276
2020 Q1	$105K	Hold	215,000	–	–	0.01%	412
2019 Q4	$135K	Hold	215,000	–	–	0.01%	440
2019 Q3	$208K	Hold	215,000	–	–	0.02%	355
2019 Q2	$352K	Buy	+215,000	New	+$304K	0.03%	254
2019 Q1	–	Sell	-216,000	Closed	-$82K	–	1419
2018 Q4	$82K	Buy	216,000 +1,000	+0.5%	+$5.11K	0.01%	411
2018 Q3	$1.39M	Buy	+215,000	New	+$223K	0.15%	96

Other funds holding IGC

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.32B AUM 31.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Carroll Financial Associates's IGC Position: Q2 2021 in Review

Carroll Financial Associates sold out of IGC Pharma (IGC) in Q2 2021, closing a stake of 320,000 shares — an estimated $572K sold.

Carroll Financial Associates first reported a position in IGC in Q3 2018 and held it in 10 quarters. The position peaked at $1.39M in Q3 2018. 29 funds tracked by Wall St. Rank hold IGC as of Q2 2021.

Carroll Financial Associates reported no remaining IGC Pharma position as of Q2 2021 after selling out during the quarter.
Carroll Financial Associates sold 320,000 IGC Pharma shares in Q2 2021, an estimated $572K.
Carroll Financial Associates first reported a position in IGC Pharma in Q3 2018 and held it in 10 quarters.
Carroll Financial Associates's IGC Pharma position peaked at $1.39M in Q3 2018.
29 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2021.

Based on Carroll Financial Associates's 13F filing for Q2 2021, filed 13 Jul 2021.